HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Electronic Letters to:

Evidence-based Laboratory Medicine and Test Utilization: Christopher M. Lehman, Robert C. Blaylock, Donald P. Alexander, and George M. Rodgers Discontinuation of the Bleeding Time Test without Detectable Adverse Clinical Impact Clin Chem 2001; 47: 1204-1211 [Abstract] [Full text] [PDF]

eLetters: Submit a response to this article

Electronic letters published:

Correction

Christopher Lehman   (20 August 2001)

Correction 20 August 2001
Christopher Lehman, Medical Director U. of Utah Send letter to journal: Re: Correction lehmanc{at}aruplab.com Christopher Lehman	The authors wish to correct an error in the fourth sentence of the last paragraph on page 1207. The second half of the sentence should read "...revealed a significantly lower mean decrease in hematocrit ... for allograft kidneys ... vs native kidneys...", not a "larger mean decrease" as it appears in print. The authors apologize for any confusion this may have caused.